Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Advanced Drug Delivery Reviews|January 18, 2019
T-cells "à la CAR-T(e)" - Genetically engineering T-cell response against cancerVasyl Eisenberg, Shiran Hoogi, Astar Shamul, et al.Journal for Immunotherapy of Cancer|September 11, 2019
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor functionShiran Hoogi, Vasyl Eisenberg, Shimrit Mayer, et al.Frontiers in Immunology|November 1, 2017
Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric ReceptorVasyl Eisenberg, Katerina Shamalov, Shimrit Meir, et al.Journal for Immunotherapy of Cancer|July 4, 2024
Genetically engineering glycolysis in T cells increases their antitumor functionRaphaëlle Toledano Zur, Orna Atar, Tilda Barliya, et al.Cancer Immunology Research|July 22, 2024
Targeting Tumor-Associated Sialic Acids Using Chimeric Switch Receptors Based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T CellsVasyl Eisenberg, Shiran Hoogi, Erel Katzman, et al.Pageof 1